Astraveus appoints Dr. Lars Henrik Peeck as Chief Business Development Officer
Paris, France, 12 December 2023 – Astraveus SAS (“Astraveus” or the “Company”), the creator of the end-to-end benchtop cell factory to simplify cell and gene therapy (CGT) manufacturing, today announces the appointment of Dr. Lars Henrik Peeck as Chief Business Development Officer.
